What Happened?
Shares of genetic testing company Natera (NASDAQ: NTRA). jumped 4.3% in the afternoon session after Canaccord Genuity reiterated its Buy rating on the stock after the company's strong fourth-quarter 2025 results.
The firm's positive view came after Natera's reported results exceeded its own prior forecast. Test volume increased across the company's three main business areas. Looking ahead, Natera also provided a solid revenue forecast for 2026, showing expected year-over-year growth in the mid-20% range. This combination of a strong performance and an optimistic outlook from management appeared to boost investor confidence.
After the initial pop the shares cooled down to $207.53, up 3.7% from previous close.
Is now the time to buy Natera? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Natera’s shares are somewhat volatile and have had 12 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 4 days ago when the stock dropped 8.3% on the news that the release of a key inflation report revealed prices paid to U.S. producers rose more than anticipated in January. The Producer Price Index (PPI), which measures inflation before it reaches consumers, increased by 0.5% last month, surpassing economists' forecasts of a 0.3% rise. This report, indicating persistent inflationary pressures within the economy, sparked concerns among investors. The data suggests that the Federal Reserve might delay potential interest rate cuts that the market had been anticipating. The prospect of higher interest rates for a longer period can negatively affect corporate valuations and borrowing costs, leading to a broad market downturn that is impacting various sectors, including healthcare and medical devices.
Natera is down 9.3% since the beginning of the year, and at $207.53 per share, it is trading 18.4% below its 52-week high of $254.40 from January 2026. Investors who bought $1,000 worth of Natera’s shares 5 years ago would now be looking at an investment worth $1,909.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a $437 billion giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
